175461-33-3

Basic information

• Product Name: 2,6-dichloro-N-Methylpyridin-4-aMine
• Synonyms: 2,6-dichloro-N-Methylpyridin-4-aMine
• CAS NO: 175461-33-3
• Molecular Formula: C₆H₆Cl₂N₂
• Molecular Weight: 177.03124
• Mol File: 175461-33-3.mol
• Article Data: 7

Chemical Properties

• Melting Point: 70 °C
• Boiling Point: 312.0±37.0 °C(Predicted)
• Appearance: /
• Density: 1.404±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 0.79±0.10(Predicted)
• CAS DataBase Reference: 2,6-dichloro-N-Methylpyridin-4-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-dichloro-N-Methylpyridin-4-aMine(175461-33-3)
• EPA Substance Registry System: 2,6-dichloro-N-Methylpyridin-4-aMine(175461-33-3)

Safety Data

• Hazardous Substances Data: 175461-33-3(Hazardous Substances Data)

Usage

General Description

2,6-dichloro-N-Methylpyridin-4-aMine is a chemical compound with the molecular formula C6H6Cl2N2. It is a derivative of the pyridine compound, and it contains two chlorine atoms and one methyl group attached to the pyridine ring. 2,6-dichloro-N-Methylpyridin-4-aMine is commonly used as an intermediate in the synthesis of pharmaceutical and agrochemical products. It has also been studied for its potential use in the treatment of neurological disorders. The chemical properties and potential uses of 2,6-dichloro-N-Methylpyridin-4-aMine make it a valuable compound in various fields of research and industry.

Upstream product

• 2587-00-0 2,6-dichloropyridine N-oxide 
• 2402-78-0 2,6-dichloropyridine 
• 16063-69-7 2,4,6-trichloropyridine 
• 74-89-5 methylamine 

Downstream Products

• 887147-20-8 2,6-dichloro-N-methyl-3-nitro pyridine-4-amine 
• 914942-86-2 2,6-dichloro-4-N-methylpyridine-3,4-diamine 
• 887147-19-5 4,6-dichloro-1-methyl-1H-imidazo [4,5-c]pyridine 

Relevant articles and documents

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

The present invention discloses compounds according to Formula (I), wherein R1, R3, R4, R5, L1, and Cy are as defined herein. The present invention also provides compounds, methods for the production of said compounds of the invention, pharmaceutical compositions comprising the same and their use in allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 and/or interferons. The present invention also methods for the prevention and/or treatment of the aforementioned diseases by administering a compound of the invention.

ALKYNYL ALCOHOLS AND METHODS OF USE

The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

PYRIDINYL-PYRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS

This invention relates to novel pyridinyl-pyrazole derivatives and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associa